Searchable abstracts of presentations at key conferences in endocrinology

ea0011p400 | Diabetes, metabolism and cardiovascular | ECE2006

Recurrence rate of atrial fibrillation in amiodarone-induced hyperthyroidism

Trifanescu RA , Fica S , Dimulescu D , Barbu C , Coman I , Ceck C , Bunghez R , Coculescu M

Background: Atrial fibrillation occurs in 5–15% of hyperthyroid patients. On the other hand, amiodarone is a highly effective antiarrhythmic agent. Despite antiarrhythmic treatment, iodine-induced hyperthyroidism via amiodarone may be associated with recurrence of initial arrhythmias.Aims: To assess if amiodarone maintained it’s antiarrhythmic efficacy in the presence of amiodarone-induced hyperthyroidism (AIT).Patients a...

ea0011p259 | Diabetes, metabolism and cardiovascular | ECE2006

Subthalamic nucleus stimulation in parkinsonian patients does not increase serum ghrelin levels

Corcuff JB , Perlemoine C , Macia F , Tison F , Coman I , Guehl D , Burbaud P , Cuny E , Baillet L , Gin H , Rigalleau V

Introduction: Patients with Parkinson’s disease on pharmacological treatment frequently loose weight but regain weight after subthalamic nucleus deep brain stimulation (SNBS). This is, at least in part, due to an increase in resting energy expenditure (Perlemoine et al., Br J Nutrition 2005; 93). As SNBS electrodes are located close to the hypothalamic centre regulating food intake, we investigated whether ghrelin levels would vary with SNBS and/or L-DOPA tr...